The survey by SantésuisseExternal link, which represents health insurance companies, says Swiss citizens pay more than CHF1 billion ($1 billion) too much in health premiums. It has arrived at this conclusion by calculating how much the Swiss could save if pharmaceutical costs were at the levels of comparable European Union countries, reports the SonntagsZeitung.
Santésuisse president Heinz Brand is urging the government to act, saying it can no longer be tolerated that “numerous medicines whose patent protection has expired cost up to 100% more than in other countries”, according to the paper.
He is calling for an annual revision of prices, but this is opposed by the powerful pharmaceuticals industry because, as Anita Geiger of the Interpharma association is quoted as saying, “the costs for the authorities and companies would triple and be out of proportion to the cost savings”.
The cost of compulsory health insurance has continued to rise, although the increase was more modest this year, and is a major burden on many people’s incomes.
More
More
High pharma margins squeeze health systems
This content was published on
Curing cancer for the masses could be challenging if healthcare systems are crippled by rapidly rising cancer drug prices.
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
This content was published on
The parents of the young jihadist who left for Syria to join the Islamic State have been given suspended sentences by the Federal Criminal Court.
This content was published on
Felix Lehner, Pamela Rosenkranz and Miroslav Sik have been awarded the Swiss Grand Award for Art/Prix Meret Oppenheim 2025.
Nearly 2% of new Swiss disability insurance claims involve Long Covid
This content was published on
Just under 2% of new claims submitted to the disability insurance between 2021 and 2023 concern people suffering from Long Covid.
This content was published on
The watch industry had to contend with a weakening of its exports last year, which reached a volume of CHF25.9 billion ($28.5 billion).
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
New health insurance premiums are ‘good news’ for most
This content was published on
While many in Switzerland can look forward to lower health insurance premiums next year, some will be paying nearly 3% more.
Pharma marketing budgets slammed by health insurers
This content was published on
The SonntagsZeitungExternal link newspaper says that the marketing budget of Swiss pharma giant Novartis has risen 20% in the last four years to CH12 billion ($12 billion), eclipsing the CHF9 billion spent on research. Roche has increased marketing costs by 15% in the same period. “The marketing and distribution costs of the pharmaceutical industry are disproportionately…
Why living on the breadline is especially hard in Switzerland
This content was published on
Switzerland is one of the richest countries in the world. But high living costs put people on low income under huge pressure.
This content was published on
In an era where health care is a subject of debate in many countries, is the Swiss system serving those on moderate to low incomes?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.